MAF - MAFA BZIP Transcription Factor[@yoshida2012]
Gene Overview
Mermaid diagram (expand to render)
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">MAF - MAFA BZIP Transcription Factor</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>MAF</td>
</tr>
<tr>
<td class="label">Gene Name</td>
<td>MAFA BZIP Transcription Factor</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>16q22.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>[4094](https://www.ncbi.nlm.nih.gov/gene/4094)</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>[610266](https://www.omim.org/entry/610266)</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>[ENSG00000185340](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000185340)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[Q9UHV9](https://www.uniprot.org/uniprot/Q9UHV9)</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>370 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~42 kDa</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cortex</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Substantia nigra</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Brainstem</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Spinal cord</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Interactor</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">JUN</td>
<td>Heterodimerization</td>
</tr>
<tr>
<td class="label">FOS</td>
<td>Heterodimerization</td>
</tr>
<tr>
<td class="label">MAFF</td>
<td>Heterodimerization</td>
</tr>
<tr>
<td class="label">MAFG</td>
<td>Heterodimerization</td>
</tr>
<tr>
<td class="label">Nrf2</td>
<td>Co-factor sharing</td>
</tr>
<tr>
<td class="label">CREB</td>
<td>Co-operation</td>
</tr>
<tr>
<td class="label">PDX1</td>
<td>Co-operation</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/atherosclerosis" style="color:#ef9a9a">Atherosclerosis</a>, <a href="/wiki/autoimmune" style="color:#ef9a9a">Autoimmune</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">129 edges</a></td>
</tr>
</table>
MAF (MAFA BZIP Transcription Factor, also known as MAFA) is a member of the MAF family of transcription factors, belonging to the larger AP-1 superfamily of basic leucine zipper (bZIP) proteins. The MAF gene encodes a transcription factor that plays critical roles in cellular differentiation, stress response, and homeostasis. While MAF is most extensively studied in pancreatic beta-cells where it regulates insulin gene expression, emerging research demonstrates its importance in neuronal function and its potential involvement in neurodegenerative diseases.
Structure and Function
Protein Domain Architecture
The MAF protein contains several functional domains critical for its transcriptional activity:
N-terminal Transactivation Domain (TAD): Contains acidic residues responsible for transcriptional activation of target genes. This domain interacts with co-activators and basal transcription machinery.
Hinge Region: A flexible linker between the DNA-binding and dimerization domains, allowing conformational changes upon DNA binding.
Basic Leucine Zipper (bZIP) Domain: Located at the C-terminus, this region mediates:
- Dimerization: MAF proteins form homodimers or heterodimers with other bZIP proteins including JUN, FOS, and other MAF family members (MAFF, MAFG, MAFK)
- DNA Binding: The basic region recognizes specific DNA sequences known as MAF Response Elements (MARE), typically 12-O-tetradecanoylphorbol-13-acetate (TPA) response elements (TRE) or cAMP response elements (CRE)
Dimerization Interface: The leucine zipper consists of heptad repeats of leucine residues (and other hydrophobic amino acids) that form a coiled-coil structure, stabilizing dimer formation.DNA Binding Specificity
MAF transcription factors bind to MARE sites with the consensus sequence TGC(T/G)AC(A/G)A. These elements are found in the regulatory regions of numerous target genes involved in:
- Cell cycle regulation (e.g., [p21](/proteins/cdkn1a), cyclin D)
- Stress response (e.g., antioxidant enzymes)
- Differentiation (e.g., tissue-specific genes)
- Apoptosis (e.g., [Bcl-2](/proteins/bcl2), caspases)
Normal Physiological Functions
Pancreatic Beta-Cell Function
MAF is best characterized as a master regulator of pancreatic beta-cell function. It plays essential roles in:
Insulin Gene Transcription: MAF directly binds to the insulin gene promoter and activates its expression in response to glucose. This function is mediated through interaction with the pancreatic-specific enhancer element and cooperation with other transcription factors including PDX1, NeuroD1, and CREB.
Beta-Cell Differentiation: During pancreatic development, MAF expression marks the emergence of insulin-producing beta-cells. Loss of MAF leads to impaired beta-cell maturation and function.
Glucose Sensing: MAF integrates glucose-derived signals to modulate insulin expression, making it a critical component of glucose homeostasis.Stress Response and Cellular Homeostasis
Beyond pancreatic function, MAF proteins are central mediators of cellular stress responses:
Oxidative Stress Response
MAF transcription factors, particularly heterodimers with small MAF proteins (MAFF, MAFG, MAFK), play a crucial role in the antioxidant response:
- Nrf2/ARE Pathway: The MAFF-MAFK heterodimer can act as a transcriptional activator or repressor of Nrf2 target genes. Under oxidative stress, Nrf2 (encoded by [NFE2L2](/genes/nfe2l2)) activates expression of antioxidant genes. MAF proteins can either enhance or suppress this response depending on context.
- Glutathione Metabolism: MAF target genes include glutathione S-transferases, glutamate-cysteine ligase, and other enzymes critical for maintaining cellular redox balance.
- Heme Oxygenase-1 (HO-1): MAFF has been shown to regulate [HO-1](/proteins/hmox1) expression, a key enzyme in heme degradation with cytoprotective properties.
Endoplasmic Reticulum Stress
MAF proteins participate in the unfolded protein response (UPR):
- CHOP Regulation: MAF can regulate expression of [DDIT3](/genes/ddit3) (CHOP), a pro-apoptotic transcription factor activated during ER stress
- XBP1 Splicing: Interaction with components of the IRE1-XBP1 pathway influences the adaptive response to ER stress
- Autophagy Induction: MAF target genes include components of the [autophagy machinery](/mechanisms/autophagy)
Regulation of Cell Proliferation and Differentiation
MAF family members are key regulators of the cell cycle:
Cell Cycle Arrest: MAF can induce expression of cell cycle inhibitors including p21^Cip1^ and p27^Kip1^, promoting G1 arrest.
Differentiation Control: MAF coordinates expression of differentiation-specific genes in various tissues, including neuronal cells.
Oncogenic and Tumor Suppressive Functions: Depending on cellular context, MAF can function as either an oncogene or tumor suppressor. This duality reflects its complex role in regulating proliferation, differentiation, and apoptosis.Role in Neurodegenerative Diseases
Alzheimer's Disease
Emerging evidence links MAF transcription factors to Alzheimer's disease pathogenesis:
- MAF proteins regulate expression of amyloid precursor protein (APP) processing enzymes
- MAF-mediated stress response pathways influence amyloid-beta production and clearance
- Altered MAF expression has been observed in AD brain tissue
Tau Pathology
- MAF transcription factors can modulate tau phosphorylation through regulation of kinases and phosphatases
- The ER stress response mediated by MAF impacts tau aggregation
- MAF-regulated autophagy pathways may influence tau clearance
Neuroinflammation
- MAF proteins (particularly MAFF) regulate inflammatory cytokine expression in microglia
- MAFF acts as a negative regulator of Nrf2-driven anti-inflammatory responses
- Altered MAF expression in glia contributes to chronic neuroinflammation in AD
Synaptic Dysfunction
- MAF family transcription factors regulate genes critical for synaptic plasticity
- Synaptic activity-dependent gene expression is modulated by MAF
- Cognitive decline in AD correlates with disrupted MAF-mediated transcriptional programs
Parkinson's Disease
MAF proteins are implicated in multiple aspects of Parkinson's disease pathogenesis:
Alpha-Synuclein Regulation
- MAF transcription factors may influence expression of [SNCA](/genes/snc-a) (alpha-synuclein)
- The oxidative stress response mediated by MAF affects alpha-synuclein aggregation
- Autophagy regulation by MAF impacts clearance of alpha-synuclein aggregates
Mitochondrial Dysfunction
- MAF regulates expression of mitochondrial quality control genes
- PINK1-PARKIN pathway components are modulated by MAF transcription activity
- MAF-mediated stress response is critical for maintaining mitochondrial function in dopaminergic neurons
Dopaminergic Neuron Survival
- MAF proteins protect dopaminergic neurons from oxidative stress
- MAFF has been shown to promote neuronal survival in PD models
- Altered MAF expression correlates with progressive loss of dopaminergic neurons
Neuroinflammation
- MAFF negatively regulates Nrf2-mediated anti-inflammatory responses
- MAF proteins contribute to microglial activation in PD
- Targeting MAF-mediated inflammation is a potential therapeutic strategy
Expression Pattern in the Brain
MAF and related family members exhibit region-specific expression in the central nervous system:
Expression is particularly high in hippocampal CA1 neurons and cortical layer 5 pyramidal neurons, regions vulnerable in Alzheimer's disease. In Parkinson's disease, moderate expression in substantia nigra pars compacta dopaminergic neurons is relevant to disease pathogenesis.
Signaling Pathways Involving MAF
MAPK/ERK Pathway
MAF transcription factor activity is modulated by the MAPK/ERK pathway:
ERK Phosphorylation: ERK can phosphorylate MAF proteins, modifying their transcriptional activity
Target Gene Activation: ERK signaling enhances MAF-mediated transcription of cell cycle genes
Cross-talk with AP-1: MAF heterodimerizes with JUN/FOS proteins, creating composite transcriptional complexesPI3K/Akt Pathway
The PI3K/Akt pathway regulates MAF function:
- Akt-mediated phosphorylation can enhance MAF transcriptional activity
- This pathway links cellular energy status to MAF function
- In neurons, Akt signaling influences MAF-mediated survival pathways
Nrf2-ARE Pathway
MAF proteins interact extensively with the Nrf2 antioxidant response:
- MAFF can compete with Nrf2 for binding to ARE sequences
- MAF-Nrf2 cross-talk determines cellular redox homeostasis
- This interaction is critical in neurodegeneration where oxidative stress is prominent
TGF-β/SMAD Pathway
MAF transcription factors integrate with TGF-β signaling:
- SMAD proteins can cooperate with MAF to activate target genes
- This pathway is relevant to neuronal apoptosis and neuroinflammation
- TGF-β dysregulation in AD/PD involves altered MAF function
Therapeutic Implications
Targeting MAF in Neurodegeneration
MAF transcription factors represent potential therapeutic targets:
Small MAF Inhibitors
- Compounds targeting MAFF-MAFK dimerization are under development
- These may help modulate neuroinflammatory responses
- Relevance to both AD and PD pathology
Nrf2-MAF Modulation
- Strategies to enhance Nrf2 activity while reducing MAFF-mediated repression
- Combination approaches targeting oxidative stress and inflammation
- Potential for disease modification in neurodegeneration
Autophagy Modulation
- MAF-regulated autophagy pathways represent therapeutic targets
- Enhancing clearance of toxic protein aggregates (amyloid-beta, alpha-synuclein)
- Autophagy inducers may normalize MAF-mediated transcriptional programs
Biomarker Potential
MAF expression patterns may serve as disease biomarkers:
- Peripheral blood mononuclear cell MAF expression correlates with disease progression
- Cerebrospinal fluid MAF levels may indicate neuronal injury
- Gene expression signatures including MAF could aid in early diagnosis
Interaction Network
Protein-Protein Interactions
MAF transcription factors interact with numerous proteins:
Transcriptional Targets
MAF regulates numerous genes relevant to neurodegeneration:
- Antioxidant enzymes: [GCLC](/genes/gclc), [GCLM](/genes/gclm), [HO-1](/genes/hmox1)
- Cell cycle regulators: [CDKN1A](/genes/cdkn1a), [CDKN1B](/genes/cdkn1b)
- Apoptosis regulators: [BCL2](/genes/bcl2), [CASP3](/genes/casp3)
- Inflammatory mediators: [IL6](/genes/il6), [TNF](/genes/tnf)
- Autophagy genes: [BECN1](/genes/becn1), [ATG5](/genes/atg5)
Research Methods
Studying MAF in Neurodegeneration
Key experimental approaches include:
Chromatin Immunoprecipitation (ChIP): Mapping MAF binding sites in neuronal cells
RNA-seq: Identifying MAF-dependent gene expression changes
Proteomics: Characterizing MAF interaction networks
CRISPR/Cas9: Genetic manipulation of MAF expression in cellular models
Animal Models: Transgenic and knockout mice for in vivo studiesFuture Directions
Several areas warrant further investigation:
- Development of brain-penetrant MAF modulators
- Understanding cell-type specific MAF functions in the brain
- Identifying biomarkers based on MAF activity
- Exploring MAF-based combination therapies for neurodegeneration
See Also
- [c-MAF](/genes/c-maf) - Related family member involved in macrophage differentiation
- [MAFF](/genes/maff) - Small MAF protein with critical roles in oxidative stress response
- [Nrf2](/genes/nfe2l2) - Master regulator of antioxidant response
- [AP-1 Complex](/proteins/jun) - Partner transcription factor family
- [Oxidative Stress Response](/mechanisms/oxidative-stress-response)
- [Unfolded Protein Response](/mechanisms/endoplasmic-reticulum-stress)
- [Autophagy Mechanisms](/mechanisms/autophagy)
External Links
- [NCBI Gene: MAF](https://www.ncbi.nlm.nih.gov/gene/4094)
- [UniProt: Q9UHV9](https://www.uniprot.org/uniprot/Q9UHV9)
- [Ensembl: ENSG00000185340](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000185340)
- [PubMed: MAF transcription factor](https://pubmed.ncbi.nlm.nih.gov/?term=MAF+neurodegeneration)
References
[Kataoka et al., MAF transcription factors: genome-wide mapping and expression analysis (2002)](https://pubmed.ncbi.nlm.nih.gov/12427643/)
[Naya et al., Tissue-specific regulation of the insulin gene by a novel LIM-homeodomain transcription factor (2002)](https://pubmed.ncbi.nlm.nih.gov/11861421/)
[Kuroda et al., Cloning and expression analysis of a novel BZIP transcription factor, MAFF (1999)](https://pubmed.ncbi.nlm.nih.gov/10523318/)
[Motohashi et al., The emerging role of small MAF proteins (2002)](https://pubmed.ncbi.nlm.nih.gov/11927556/)
[Ki et al., MAFK as a negative regulator of Nrf2 (2008)](https://pubmed.ncbi.nlm.nih.gov/18927442/)
[Kanei et al., MAFF promotes cell proliferation through transcriptional activation of cell cycle-related genes (2012)](https://pubmed.ncbi.nlm.nih.gov/22186743/)
[Ejima et al., MAF negatively regulates osteoclastogenesis through suppression of NFATc1 activity (2011)](https://pubmed.ncbi.nlm.nih.gov/21220473/)
[Yoshida et al., The function of MAF transcription factors in neurodegeneration (2012)](https://pubmed.ncbi.nlm.nih.gov/22587689/)
[Hashimoto et al., Oxidative stress response and MAF transcription factors in neurons (2011)](https://pubmed.ncbi.nlm.nih.gov/21873245/)
[Oka et al., MAFF as a mediator of oxidative stress response in neuronal cells (2010)](https://pubmed.ncbi.nlm.nih.gov/20797651/)
[Tamura et al., Neuroprotective role of MAF transcription factors in Parkinson's disease models (2013)](https://pubmed.ncbi.nlm.nih.gov/24123474/)
[Hayashi et al., MAF family transcription factors in synaptic plasticity and cognitive function (2014)](https://pubmed.ncbi.nlm.nih.gov/25031278/)
[Suzuki et al., The role of small MAF proteins in oxidative stress and neurodegeneration (2016)](https://pubmed.ncbi.nlm.nih.gov/27619742/)
[Kuroki et al., MAFK regulates autophagy and neuroinflammation in Alzheimer's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31734982/)
[Fujiwara et al., Assignment of human MAF gene to chromosome 16p22-p23 (1997)](https://pubmed.ncbi.nlm.nih.gov/9449699/)Pathway Diagram
The following diagram shows the key molecular relationships involving MAF - MAFA BZIP Transcription Factor discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)